Tag: $Metsera

Shares of Metsera, fell nearly 15% in premarket trading on Monday, after the weight-loss drug developer accepted a sweetened offer from Pfizer, to end a fierce bidding war between the pharma giant and Danish rival Novo Nordisk.

 Pfizer (PFE.N), said on Monday it would acquire weight-loss drug developer Metsera (MTSR.O), in a deal valued at up to $7.3 billion, including future payments, to secure its position in the lucrative obesity treatment market.